Author

F. Paul

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Organism:mouse· 1

Frequent Co-Authors

A. E. Hauser· 1 shared A. F. Florez· 1 shared A. Joly· 1 shared A. Narla· 1 shared B. Nicke· 1 shared C. Herrmann· 1 shared C. Shao· 1 shared C. Stresemann· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. E. Hauser

Author profile →

3 papers

Recent·Most cited

Arginine-dependent hypusination of the eukaryotic translation initiation factor (eIF)5A drives erythroid lineage differentiation

P. Gonzalez-Menendez, I. Phadke, M. E. Olive, K. L. McGraw, J. Platon, J. Papoin, H. Yan, M. Daumur, F. Paul, R. Mirmira, A. Joly, J. Galtier, A. Narla, G. Cartron, V. Dardalhon, , N. Taylor

The paper shows that arginine metabolism via hypusination of eIF5A regulates erythroid differentiation and that impaired eIF5A activity leads to erythroid disorders.

bioRxiv · Mar 21, 2022 · PreprintPhysiology

MYCN mediates cysteine addiction and sensitizes to ferroptosis

H. Alborzinia, A. F. Florez, S. Gogolin, L. M. Brueckner, C. Shao, M. Gartlgruber, M. Nadler Holly, M. Ziehm, F. Paul, S. Steinhauser, E. Bell, M. Shaikhkarami, S. Hartlieb, D. Dreidax, E. M. Hess, , F. Westermann

This study shows MYCN promotes cysteine addiction and ferroptosis resistance in neuroblastoma, identifying therapeutic targets for ferroptosis induction.

bioRxiv · Aug 10, 2021 · PreprintCancer Biology

Low-Density Granulocytes are a novel immunopathological feature in both Multiple Sclerosis and Neuromyelitis optica spectrum disorder.

L. Ostendorf, R. Mothes, S. van Koppen, R. L. Lindquist, J. Bellmann-Strobl, S. Asseyer, K. Ruprecht, T. Alexander, R. A. Niesner, A. E. Hauser, F. Paul, H. Radbruch

The paper identifies low-density granulocytes (LDGs) as an immunophenotypic feature in multiple sclerosis and neuromyelitis optica spectrum disorder patients.

bioRxiv · Jun 12, 2019Immunology